CHLAMYDIA TRACHOMATIS IMMUNIZATION

Clinical trials for CHLAMYDIA TRACHOMATIS IMMUNIZATION explained in plain language.

Never miss a new study

Get alerted when new CHLAMYDIA TRACHOMATIS IMMUNIZATION trials appear

Sign up with your email to follow new studies for CHLAMYDIA TRACHOMATIS IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First-Ever mRNA vaccine for chlamydia enters human testing

⭐️ VACCINE ⭐️ Recruiting now

This study is testing a new mRNA vaccine designed to prevent chlamydia infection. It will involve 1,560 healthy adults aged 18 to 29 who are at higher risk for sexually transmitted infections. Researchers will give different vaccine doses to assess safety and see if it triggers a…

Matched conditions: CHLAMYDIA TRACHOMATIS IMMUNIZATION

Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️

Last updated Apr 15, 2026 16:15 UTC

CHLAMYDIA TRACHOMATIS IMMUNIZATION

Get alerted when new CHLAMYDIA TRACHOMATIS IMMUNIZATION trials appear

First-Ever mRNA vaccine for chlamydia enters human testing